Sort   by:  
 Page size 
UnknownDevelopment of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma.
Not available
S-EPMC8534163 | biostudies-literature
UnknownA mouse model of human TLR4 D299G/T399I SNPs reveals mechanisms of altered LPS and pathogen responses.
Not available
S-EPMC7685774 | biostudies-literature
UnknownSpatial cell type composition in normal and Alzheimers human brains is revealed using integrated mouse and human single cell RNA sequencing.
Not available
S-EPMC7582925 | biostudies-literature
UnknownIndole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3.
Not available
S-EPMC7365739 | biostudies-literature
TranscriptomicsGlobal gene expression analysis of anthracycline-resistant breast cancer cell lines
Drug resistance in breast cancer is the major obstacle to a successful outcome following chemotherapy treatment. While upregulation of multidrug resistance (MDR) genes is a key component of drug resistance in multiple cancers, the complexity and hierarchy of non-MDR driven drug resistance pathways a...
ORGANISM(S): Homo sapiens 
2014-01-24 | E-GEOD-54326 | biostudies-arrayexpress
UnknownA randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Not available
S-EPMC3324323 | biostudies-literature
UnknownPharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
Not available
S-EPMC5763501 | biostudies-literature
TranscriptomicsICGC Pancreas: Genomic analysis reveals roles for chromatin modification and axonguidance in pancreatic cancer
Pancreatic cancer (PC) is the fourth leading cause of cancer death with an overall 5-year survival rate of < 5%, a statistic that has changed little in almost 50 years. A deeper understanding of the underlying molecular pathophysiology is expected to advance the urgent need to develop novel therapeu...
ORGANISM(S): Homo sapiens 
2012-03-30 | E-GEOD-36924 | biostudies-arrayexpress
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
GenomicsQCMG_20130826 - samples
Analysis .bam files from HiSeq sequencing of Australian ICGC PDAC study samples, submitted 20130826
EGAD00001000660 | EGA
Sort   by:  
 Page size